Putin has pushed inoculation since touting Russia’s approval of Sputnik V in Aug as the globe’s first Covid shot. But many nations have been unwilling to give it fast-track approval.
Argentina joins North America, EU, UK, China and Chile in offering preventive shots. It also boosts Russia’s attempts to push the vaccine into developing nations.
Based on a monkey-adenovirus vector, AstraZeneca’s vaccine reported average effectiveness of 70%. Sputnik is the only Covid vaccine to use two different human-adenovirus vectors.
Calling Sputnik V a joint effort between Russia and India, RDIF CEO Kirill Dmitriev tells ThePrint that Russia is keen to collaborate with other countries on development of Covid vaccines.
Russian Direct Investment Fund has tied up with Hetero for production of Sputnik V Covid vaccine. Dr Reddy’s is currently conducting clinical trials of the vaccine in India.
According to Gamelya National Centre and the Russian Direct Investment Fund, as of 24 November, no unexpected adverse events were identified during the trials.
According to officials, the decision to conduct the human clinical trials was taken after Dr Reddy's Laboratories got approval from the Drugs Controller General of India.
The high efficacy rate is based on 20 confirmed Covid-19 cases that were split across vaccinated subjects who got two doses and those who got the placebo.
Whether it is due to the alleged unofficial ban on The Bengal Files or allegations by Gopal Mukherjee’s family against Agnihotri, everyone in the state wants to know more about Mukherjee.
New Delhi: On 4 September morning, apple growers in south Kashmir’s Pulwama woke up to knee-deep water in their orchards, ripe apples scattered all over,...
New Delhi: Army chief General Upendra Dwivedi has strongly backed the idea of theaterisation, saying it is inevitable and the need of the hour.
Speaking...
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS